PL3246325T3 - Kryształy związku 2-acyloamino-tiazolu - Google Patents

Kryształy związku 2-acyloamino-tiazolu

Info

Publication number
PL3246325T3
PL3246325T3 PL17176670T PL17176670T PL3246325T3 PL 3246325 T3 PL3246325 T3 PL 3246325T3 PL 17176670 T PL17176670 T PL 17176670T PL 17176670 T PL17176670 T PL 17176670T PL 3246325 T3 PL3246325 T3 PL 3246325T3
Authority
PL
Poland
Prior art keywords
compound crystals
acylaminothiazole
acylaminothiazole compound
crystals
compound
Prior art date
Application number
PL17176670T
Other languages
English (en)
Inventor
Keizo Sugasawa
Akio Miyafuji
Kenichi Suzuki
Yuji Awamura
Original Assignee
Astellas Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc. filed Critical Astellas Pharma Inc.
Publication of PL3246325T3 publication Critical patent/PL3246325T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
PL17176670T 2011-08-03 2012-08-01 Kryształy związku 2-acyloamino-tiazolu PL3246325T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2011169730A JP2014144916A (ja) 2011-08-03 2011-08-03 2−アシルアミノチアゾール化合物の結晶
EP12759833.2A EP2739621B1 (en) 2011-08-03 2012-08-01 2-acylaminothiazole compound crystals
PCT/JP2012/004885 WO2013018362A1 (en) 2011-08-03 2012-08-01 2-acylaminothiazole compound crystals
EP17176670.2A EP3246325B1 (en) 2011-08-03 2012-08-01 2-acylaminothiazole compound crystals

Publications (1)

Publication Number Publication Date
PL3246325T3 true PL3246325T3 (pl) 2020-07-27

Family

ID=46875935

Family Applications (2)

Application Number Title Priority Date Filing Date
PL17176670T PL3246325T3 (pl) 2011-08-03 2012-08-01 Kryształy związku 2-acyloamino-tiazolu
PL12759833T PL2739621T3 (pl) 2011-08-03 2012-08-01 Kryształy związku 2-acyloamino-tiazolu

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL12759833T PL2739621T3 (pl) 2011-08-03 2012-08-01 Kryształy związku 2-acyloamino-tiazolu

Country Status (15)

Country Link
EP (2) EP2739621B1 (pl)
JP (1) JP2014144916A (pl)
CY (2) CY1120647T1 (pl)
DK (2) DK3246325T3 (pl)
ES (2) ES2636749T3 (pl)
HK (1) HK1246793A1 (pl)
HR (2) HRP20171214T1 (pl)
HU (1) HUE034270T2 (pl)
LT (3) LT2739621T (pl)
NO (1) NO2020032I1 (pl)
PL (2) PL3246325T3 (pl)
PT (2) PT2739621T (pl)
RS (1) RS60358B1 (pl)
SI (2) SI3246325T1 (pl)
WO (1) WO2013018362A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2764866A1 (en) 2013-02-07 2014-08-13 IP Gesellschaft für Management mbH Inhibitors of nedd8-activating enzyme
CN106749226B (zh) * 2017-03-15 2019-12-20 广东赛拓医药科技有限公司 一种avatrombopag马来酸盐晶型C的制备方法
WO2020044364A1 (en) 2018-08-27 2020-03-05 Mylan Laboratories Limited Polymorphic forms of avatrombopag maleate
CN112022825B (zh) * 2020-08-24 2024-03-22 瑞阳制药股份有限公司 马来酸阿伐曲泊帕片剂及其制备方法
CN112409350B (zh) * 2020-11-27 2023-12-19 上海迪赛诺生物医药有限公司 一种马来酸阿伐曲泊帕晶型c的制备方法
CN113185510B (zh) * 2021-04-12 2022-05-13 南京海纳医药科技股份有限公司 一种阿伐曲泊帕杂质的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2416304T3 (es) 2002-01-18 2013-07-31 Astellas Pharma Inc. Derivado de 2-acilaminotiazol o sal del mismo
AU2003268687A1 (en) 2002-09-30 2004-04-19 Yamanouchi Pharmaceutical Co., Ltd. Novel salt of 2-acylaminothiazole derivative

Also Published As

Publication number Publication date
PT3246325T (pt) 2020-04-21
CY1120647T1 (el) 2019-12-11
HK1246793A1 (zh) 2018-09-14
HRP20200546T1 (hr) 2020-08-07
EP3246325A1 (en) 2017-11-22
ES2784384T3 (es) 2020-09-24
DK2739621T3 (en) 2017-09-04
EP2739621B1 (en) 2017-06-21
ES2636749T3 (es) 2017-10-09
WO2013018362A1 (en) 2013-02-07
SI3246325T1 (sl) 2020-07-31
EP2739621A1 (en) 2014-06-11
NO2020032I1 (no) 2020-09-14
PL2739621T3 (pl) 2017-12-29
PT2739621T (pt) 2017-08-16
DK3246325T3 (da) 2020-04-20
SI2739621T1 (sl) 2017-10-30
LT2739621T (lt) 2017-09-25
JP2014144916A (ja) 2014-08-14
CY1122974T1 (el) 2021-10-29
LT3246325T (lt) 2020-05-11
LTPA2020526I1 (lt) 2020-09-25
HRP20171214T1 (hr) 2017-10-20
EP3246325B1 (en) 2020-03-25
RS60358B1 (sr) 2020-07-31
HUE034270T2 (en) 2018-02-28

Similar Documents

Publication Publication Date Title
IL286152A (en) Modified imidazopyridinyl-aminopyridine compounds
ZA201401553B (en) Cyclopropaneamine compound
GB201106817D0 (en) New compound
GB201109763D0 (en) Compounds
GB201106395D0 (en) Compounds
GB201107197D0 (en) Compounds
EP2725011A4 (en) NEW COMPOUND
HK1246793A1 (zh) 2-酰氨基噻唑化合物晶體
EP2708540A4 (en) PYRIMIDO-DIAZEPINONE COMPOUND
GB201122305D0 (en) Novel compound
GB201110938D0 (en) Compounds
GB201105659D0 (en) Compounds
GB201112987D0 (en) Novel compound
GB201118613D0 (en) Compounds
GB201104669D0 (en) Compound
HUE050301T2 (hu) 2-Acilamino-tiazol-vegyület kristályok
GB201121538D0 (en) Compound
GB201118102D0 (en) Compound
GB201119745D0 (en) Compounds
GB201119703D0 (en) Compounds
GB201115829D0 (en) Compounds
GB201115828D0 (en) Compounds
GB201115827D0 (en) Compounds
GB201114195D0 (en) Compounds
GB201111440D0 (en) Compounds